Literature DB >> 8205675

Body fat and sympathetic nerve activity in healthy subjects.

U Scherrer1, D Randin, L Tappy, P Vollenweider, E Jéquier, P Nicod.   

Abstract

BACKGROUND: Obesity is associated with an increased incidence of cardiovascular complications, but the underlying mechanism is unknown. In experimental animals, overfeeding is associated with sympathetic activation, and there is evidence that adrenergic mechanisms contribute to cardiovascular complications. METHODS AND
RESULTS: We recorded resting postganglionic sympathetic nerve discharge (using intraneural microelectrodes) to skeletal muscle blood vessels in 37 healthy subjects covering a broad spectrum of percent body fat. To assess potential functional consequences of sympathetic nerve discharge, we simultaneously measured calf vascular resistance and energy expenditure. The resting rate of sympathetic nerve discharge to skeletal muscle was directly correlated with body mass index (r = .67, P < .0001) and percent body fat (r = .64, P < .0001). In addition to body fat, muscle sympathetic nerve activity was correlated with age (r = .40, P < .02), plasma insulin concentration (r = .34, P < .04), and plasma lactate concentration (r = .35, P < .04). Together, these four covariates accounted for 58% of the variance of muscle sympathetic nerve activity (P < .0001). The rate of sympathetic nerve discharge to calf blood vessels was directly correlated with calf vascular resistance (r = .40, P < .02) but did not predict energy expenditure (r = .22, P = .19).
CONCLUSIONS: In healthy humans, body fat is a major determinant of the resting rate of muscle sympathetic nerve discharge. Overweight-associated sympathetic activation could represent one potential mechanism contributing to the increased incidence of cardiovascular complications in overweight subjects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8205675     DOI: 10.1161/01.cir.89.6.2634

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  63 in total

Review 1.  Obesity and autonomic function.

Authors:  S D Beske; J A Taylor
Journal:  Clin Auton Res       Date:  2001-04       Impact factor: 4.435

Review 2.  Autonomic dysfunction in programmed hypertension.

Authors:  Hasthi U Dissanayake; Michael R Skilton; Jaimie W Polson
Journal:  J Hum Hypertens       Date:  2018-12-05       Impact factor: 3.012

3.  Acute sex hormone suppression reduces skeletal muscle sympathetic nerve activity.

Authors:  Danielle S Day; Wendolyn S Gozansky; Christopher Bell; Wendy M Kohrt
Journal:  Clin Auton Res       Date:  2011-06-03       Impact factor: 4.435

Review 4.  The global epidemic of obesity: are we becoming more sympathetic?

Authors:  Kevin P Davy
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

Review 5.  Selective leptin resistance revisited.

Authors:  Allyn L Mark
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-24       Impact factor: 3.619

6.  Increased incidence of diuretic use in critically ill obese patients.

Authors:  Emma J de Louw; Pepijn O Sun; Joon Lee; Mengling Feng; Roger G Mark; Leo Anthony Celi; Kenneth J Mukamal; John Danziger
Journal:  J Crit Care       Date:  2015-02-07       Impact factor: 3.425

7.  Disparity of autonomic control in type 2 diabetes mellitus.

Authors:  R J Huggett; E M Scott; S G Gilbey; J Bannister; A F Mackintosh; D A S G Mary
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

8.  Increase in muscle nerve sympathetic activity after glucose intake is blunted in the elderly.

Authors:  J Fagius; K Ellerfelt; H Lithell; C Berne
Journal:  Clin Auton Res       Date:  1996-08       Impact factor: 4.435

9.  Adiposity-independent sympathetic activity in black men.

Authors:  Aamer Abbas; Lidia S Szczepaniak; Meryem Tuncel; Jonathan M McGavock; Beverley Huet; Paul J Fadel; Zhongyun Wang; Debbie Arbique; Ronald Victor; Wanpen Vongpatanasin
Journal:  J Appl Physiol (1985)       Date:  2010-03-18

Review 10.  The sympathetic nervous system alterations in human hypertension.

Authors:  Guido Grassi; Allyn Mark; Murray Esler
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.